Author

T. Vausselin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

J. Dubuisson· 2 shared P. Brodin· 2 shared Y. Rouille· 2 shared A. Biela· 1 shared A. Danneels· 1 shared A. Dembele· 1 shared A. Machelart· 1 shared A. T. Foe· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Dubuisson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

S. Belouzard, A. Machelart, V. Sencio, T. Vausselin, E. Hoffmann, N. Deboosere, Y. Rouille, L. Desmarets, K. Seron, A. Danneels, C. Robil, L. Belloy, C. Moreau, C. Piveteau, A. Biela, , J. Dubuisson

This paper identifies clofoctol as an antiviral against SARS-CoV-2, showing it inhibits viral replication and reduces lung pathology in mice.

bioRxiv · Jun 30, 2021 · PreprintMicrobiology

An Arginine-Rich Motif in the ORF2 Capsid Protein Regulates the Hepatitis E Virus Lifecycle and Interactions with the Host Cell

K. Hervouet, M. Ferrie, M. Ankavay, C. Montpellier, C. Camuzet, V. Alexandre, A. Dembele, C. Lecoeur, A. T. Foe, P. Bouquet, D. Hot, T. Vausselin, J.-M. Saliou, S. Salome-Desnoulez, L. Marsollier, , L. Cocquerel

This study identifies an Arginine-Rich Motif in the HEV ORF2 capsid protein that regulates its subcellular localization, functionality, and interactions with host cells, revealing its central role in the HEV lifecycle.

bioRxiv · May 26, 2021Microbiology

Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model

M. Dent, K. Hamorsky, T. Vausselin, J. D. Dubuisson, Y. Miyata, Y. Morikawa, N. Matoba

This paper evaluates the safety and efficacy of Avaren-Fc, a HCV-targeting lectibody, in a human liver chimeric mouse model, showing it prevents HCV infection without toxicity.

bioRxiv · Apr 22, 2020Pharmacology & Toxicology